DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Frederiksen MT, Ainsworth MA, Brynskov J. et al.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.
Inflamm Bowel Dis 2014;
20: 1714-1721
We do not assume any responsibility for the contents of the web pages of other providers.